Pregabalin 25 mg capsules: Supply issue

Supply issue Active

There is a supply issue with pregabalin 25 mg capsules (Pharmacode 2534053). We are removing all-at-once dispensing from 8 March 2022.

Affected product

There is limited supply of cap 25 mg Pregabalin Pfizer, Pharmacode 2534053.

Schedule listing for pregabalin(external link)

This supply issue only affects the 25 mg capsule presentation. There is normal stock of other presentations.

Monthly dispensing from 8 March 2022

To extend the availability of pregabalin 25 mg capsules pharmacists should only dispense monthly lots until further notice.

Other strengths can be dispensed all-at-once. 

RxOne: The changes will be automatically updated by RxOne from the effective date.

Toniq: The changes will automatically be updated in Toniq medicine databases from the effective date.

MoH: Please note that the Ministry of Health Sector Operations Group will be able to process these claims in March 2022 in the normal claim cycle.

Resupply expected by early April 2022

We are working closely with the supplier on resupply. If the resupply date changes, we will update this web page. 

Due to COVID-19 cases we are experiencing some challenges within the supply chain. 

Read our COVID-10 supply chain update

For people taking pregabalin 25 mg capsules

You will need to return to the pharmacy each month to collect your prescription. You will only have to pay the co-payment once (usually $5). 

We know that monthly dispensing can be inconvenient. We have taken these steps to ensure everyone can continue to receive their medicine. Thank you for your patience.

Who to contact

If you have questions about this supply issue, email enquiry@pharmac.govt.nz